Dr Manzanilla Pediatric by is a Otc medication manufactured, distributed, or labeled by Key Therapeutics. Drug facts, warnings, and ingredients follow.
DR MANZANILLA PE- phenylephrine hydrochloride, triprolidine hydrochloride syrup
Key Therapeutics
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Dr. Manzanilla PE
Key Therapeutics, LLC
Disclaimer: Most OTC drugs are not reviewed and approved by FDA; however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Dr. Manzanilla PE Syrup
Drug Facts
temporarily relieves these symptoms due to common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
Do not exceed recommended dosage.
Ask a doctor before use if you are taking sedatives or tranquilizers
In case of overdose, get medical help or contact a Poison Control Center right away.
Do not exceed recommended dosage.
AGE | DOSE |
Adults and Children 12 years of age and older: | 1 teaspoonful (5 mL) every 4 hours, not to exceed 4 teaspoonfuls (20 mL) in 24 hours or as directed by a doctor. |
Children 6 to under 12 years of age: | ½ teaspoonful (2.5 mL) every 4 hours, not to exceed 2 teaspoonfuls (10 mL) in 24 hours or as directed by a doctor. |
Children under 6 years of age: | Consult a doctor |
Store at 15°-30° C (59°-86° F).
Tamper evident by foil seal under cap. Do not use if foil seal is missing or broken. Dispense in a tight, light-resistant container with a child-resistant cap.
DR MANZANILLA PE
phenylephrine hydrochloride, triprolidine hydrochloride syrup |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Key Therapeutics (080318791) |